Evidence map›Paper›PMID 33822657›Full record

ReviewAmerican journal of speech-language pathology2021

Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future.

Katlyn Elizabeth McGrattan, Robert J Graham, Christine J DiDonato, Basil T Darras

Open access · hybridAbstract readReview
In one paragraph

Review in American journal of speech-language pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Classifying neurogenic dysphagia as a movement disorder.Brain : a journal of neurology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Swallowing function in patients with spinal muscular atrophy before and after the introduction of new gene-based therapies: what has changed?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  18. Fiberoptic endoscopic evaluation of swallowing (FEES) in children with spinal muscular atrophy type 1: feasibility, swallowing safety and efficacy, and dysphagia phenotype.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Katlyn Elizabeth McGrattanDepartment of Speech-Language-Hearing Science, University of Minnesota, Minneapolis.
Robert J GrahamDepartment of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, MA.
Christine J DiDonatoDepartment of Pediatrics, Northwestern University, Chicago, IL.
Basil T DarrasDepartment of Neurology, Boston Children's Hospital, MA.
Boston Children's Hospital · USGoogle (United States) · USNorthwestern University · US

Funding

Spinal Muscular Atrophy: Inducing SMN Expression: Administrative SupplementR01NS060926 · NINDS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DIDONATO, CHRISTINE J. · 2007 to 2017
$3.4M
Long-term effect of troponin activators for spinal muscular atrophyR21NS103107 · NINDS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DIDONATO, CHRISTINE J. · 2017 to 2018
$429k
A novel non-invasive method of aspiration detection in preterm infants.R41HD104305 · NICHD · NUBORN MEDICAL, INC. · PI MCGRATTAN, KATLYN ELIZABETH · 2020 to 2020
$256k
NICHD NIH HHS R41 HD104305NINDS NIH HHS R01 NS060926NINDS NIH HHS R21 NS103107
6 · The paper itself

Abstract

Purpose The aim of this study was to provide clinicians with an overview of literature relating to dysphagia in spinal muscular atrophy (SMA) to guide assessment and treatment. Method In this clinical focus article, we review literature published in Scopus and PubMed between 1990 and 2020 pertaining to dysphagia in SMA across the life span. Original research articles that were published in English were included. Searches were conducted within four themes of inquiry: (a) etiology and phenotypes, (b) respiratory systemic deficits and management, (c) characteristics of natural history dysphagia and its treatment, and (d) dysphagia outcomes with disease-modifying therapies. Articles for the first two themes were selected by content experts who identified the most salient articles that would provide clinicians foundational background knowledge about SMA. Articles for the third theme were identified using search terms, including

Indexed as

Deglutition DisordersMuscular Atrophy, SpinalBiological ProductsHumansPhenotypeRecombinant Fusion ProteinsResearch DesignBiological ProductsRecombinant Fusion ProteinsZolgensma

Identifiers

PMID33822657
PMCPMC8702868
OpenAlexW3146408482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.